Effectiveness of Diclofenac in the form of transdermal patch and oral tablet after tooth extraction

Efficacy of oral Diclofenac and transdermal patch after posterior tooth extraction-A split mouth study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030229

Enrollment

Registered

2021-01-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M267- Dental alveolar anomalies

Interventions

Intervention1: Diclofenac transdermal patch: Diclofenac transdermal patch 100mg ,given once daily for 3 days Control Intervention1: Diclofenac patch and diclofenac tablet: 100mg of transdermal patch g

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are willing to participate in the study 2.Patients who need bilateral posterior tooth extraction. 3.Male and female patients of age 18-55 years 4.Individuals under ASA I and II.

Exclusion criteria

Exclusion criteria: 1.Reported allergy or hypersensitivity to, NSAIDs or any other drugs. 2.Pregnant or lactating ladies. 3.History of systemic diseases like bronchial asthma, active peptic ulcer, epilepsy 4.Trans alveolar extractions •Infected tooth with periapical lesions •Subjects undergoing treatment with other NSAIDs or other analgesics during the trial period.

Design outcomes

Primary

Measure	Time frame
1.Pain intensityTimepoint: First day,Second day,Third day	—

Secondary

Measure	Time frame
1. Pain reliefTimepoint: First day,Second day,Third day	—

Countries

India

Contacts

Public ContactAhana Mol U K

PMS College of Dental Sciences and Research

surejkumarlk@gmail.com9447032516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026